Stacy Loretz Congdon
Analyst
Thanks, Tom, and good morning, everyone. I'd like to start my comments with a brief discussion of our earnings per share for the quarter and the year. Diluted EPS for the fourth quarter was $0.62 compared to $0.65 last year. For those of you that model EPS excluding LIFO expense, this translates to $0.69 for the quarter compared to $0.65 last year, a 6.2% improvement. For the year, diluted EPS was $1.83 in 2014 compared to $1.79 for 2013. We had guided to a range of $1.68 to $1.76 and beat that expectation due primarily to our LIFO expense coming in a bit lower and a better tax rate than expected. As a reminder, our LIFO expense is tied to the Producer Price Index and reflects estimates in the various product categories. Excluding LIFO expense, we earned $2.26 in 2014 compared to $2.02 last year, an 11.9% increase. This result was above the higher end of our guidance which targeted $2.17 to $2.25 per share. For 2015, we’re guiding to an EPS range between $1.84 and $1.91. This includes estimates of $16 million for LIFO expense, $8 million for cigarette holding gains, a 38% tax rate and 23.4 million dilutive shares outstanding. Excluding LIFO expense, we are guidance to an EPS range of $2.26 to $2.33. The candy gain and the net OTP tax items represented approximately $0.36 per share for 2014 and are not expected to recur in 2015. In addition, integration, acquisition, legal settlement and legacy insurance claim costs compressed 2014 EPS by approximately $0.13 per share. Normalized for just these items, guidance for 2015 EPS excluding LIFO expense indicates a range of growth between 10% to 14%. Moving on to our fourth quarter results, sales increased 4.7% to $2.6 billion compared to $2.5 billion last year. Excluding the impact of foreign currency, sales increased 5.8%. The weakness in the Canadian dollar reduced Canada’s contribution to sales by about $26 million for the quarter and nearly $90 million year-to-date. Sales in the fourth quarter were comparable for acquisitions and large account wins that were consistent in both periods. Fourth quarter cigarette sales increased 4.3% to $1.8 billion compared to $1.7 billion last year. Excluding the impact of foreign currency, cigarette sales increased 5.4% driven by a 1.3% increase in carton sales and a 3% increase in the average sales price of carton. Same-store carton sales increased 0.6% during the fourth quarter, with over half of the US divisions showing growth in this category. In contrast, industry carton shipments were down a modest 2% with carton manufacturers citing stronger consumer demand and lower gas prices. The future expectations for industry carton declines remain in the 3% to 4% range. Our non-cigarette sales increased 5.6% in Q4 to $844 million compared to $799 million in the same period last year. Excluding the impact of foreign currency, sales increased 6.6%. Food products contributed over 55% of this growth, increasing 7.2% during the quarter including foreign exchange impact. Meat and healthy snacks as well as nuts, seeds and dried fruits drove the snack category up 12%. Our fresh categories which include dairy, bread, fresh products and meat increased nearly 16% during Q4, benefiting from the Rite Aid expansion and the execution of our core strategies. Gross profit increased $11.3 million to $154.6 million, an increase of 7.9% for the fourth quarter of 2014. We recorded $7 million in net OTP tax items and the remaining holding gain associated with the candy price increase. This was offset partially by $2.7 million in LIFO expense. Cigarette holding gains in Q4 was slightly above prior year. The remaining gross profit which excludes the aforementioned items increased $7 million or 5% to $146.1 million. Remaining gross profit margins increased about 8 basis points for the quarter, but were compressed by 6 basis points due to the increase in cigarette manufacturer prices. Cigarette remaining gross profit increased 1.5% to $39.8 million, benefitting primarily from the 1.3% increase in carton sales. Remaining gross profit per carton was essentially flat for the quarter. Non-cigarette remaining gross profit increased 6.5% to $106.3 million for Q4 2014. Remaining gross profit margins for non-cigarettes increased 11 basis points. The comps for inventory shrink which was slightly higher than historical norms this quarter compared to a favorable inventory adjustment during the same period last year had a 9 basis point compressing effect. Excluding this, remaining gross profit margins increased 20 basis points, much closer to what we’ve seen in recent quarters. Moving on, operating expenses were $131.6 million in the fourth quarter this year compared to $119.5 million for the same period last year, a 10.1% increase. Operating expense as a percentage of sales increased approximately 20 basis points, driven largely by SG&A costs which I will discuss in a minute. Warehouse and delivery expenses increased $4.2 million or approximately 5.4% to $81.4 million during the fourth quarter 2014. This increase supported a comparable 5.2% increase in cubic feet handled. In addition, miles driven were up 7.6% and deliveries increased 12.6% driven by the new Rite Aid business. The increase in operating costs was offset by lower fuel costs. CNG units drove nearly 15% of total miles, up from 12% in Q3, contributing to fuel cost reduction. As a percentage to sales, warehouse and delivery was essentially flat compared to prior year. SG&A grew $7.9 million or 19% during the fourth quarter and as a percentage of sales, increased 23 basis points. Fourth quarter can often be impacted by a number of year-end adjustments and non-recurring activities, so I will point out the larger items. We saw higher stock comp versus last year’s fourth quarter when the performance shares were cancelled and bonus expense increased on good results which contributed $1.7 million collectively to this increase. In addition, we accrued $1.2 million during Q4 for settlement, litigation and related fees and another $1.9 million for legacy insurance claims, professional fees associated with the OTP tax refunds and bad debt exposure. Our health care costs were slightly higher during Q4 this year, offset by higher comparable integration costs this year versus 2013. Lastly, we reported a pension curtailment gain in SG&A last year that did not recur this year. All of these items represented a little over 70% of the increase, meaning everything else increased about 5%. The remaining increase was driven by SG&A salaries, excluding benefit. Those were up about 9%, meaning we did leverage some of the other SG&A line items. This increase in salaries was due primarily to Ohio and an investment in bench strength primary in sales, IT and some back-office functions. Moving further down the income statement, our effective tax rate for the quarter was 35.1% versus 35.3% for the fourth quarter last year. For the year, our effective tax rate was 35.7% compared to 37% last year. The decrease for the year was driven primarily by larger positive adjustments of prior year estimates and by the expiration of statutes of limitations for certain tax provisions. Moving to cash flow, cash generated from operations before working capital changes was $96 million for 2014 compared to $88 million last year, an 8.8% increase. Changes in working capital which measures two single points in resulted in a use of cash in both 2014 and 2013 of just over $29 million. The largest increase in our working capital was for cigarette inventory purchases related to our LIFO buy-in at the end of the year, which ran about $20 million higher this year compared to 2013. Free cash flow, which we measure as adjusted EBITDA plus or minus changes in working capital, less CapEx, cash taxes and cash interest, was slightly over $23 million for 2014. However, if you add back the $20 million temporary spike in inventory, we came in slightly above our expectation. Our capital investments were $54 million this year compared to $18 million in 2013. Our new Ohio division represented approximately $16 million of our total spend this year. For 2015, we are guiding back to a more normal level of $35 million for CapEx. Free cash flow per diluted share was $1.01 this year or $1.87 excluding the incremental year-end inventory buy-in. In addition, the $4 million additional CapEx spend over the $50 million we guided to represents another $0.17 a share. For 2015, we expect free cash flow to be between $65 million and $70 million, depending of course on any unusual year-end activities which I normally call out. On a per share basis, we’re expecting a range of $2.75 to $2.95 for free cash flow. Average debt for the year was $14.8 million compared to $35.3 million in 2013. Average inter-month working capital swings were approximately $55 million for the year, with our peak debt position at about $80 million in December when we started buying inventory in anticipation of the cigarette price increase. Our current ratio continues to be strong at 2 to 1 and average monthly cash conversion cycle was stable at 14 days compared to 14.3 days last year. We were able to generate sufficient excess cash in 2014 to return value to our shareholders consisting of $10.7 million in dividends and $8 million of share repurchases. And you may have noticed our first-quarter dividend announcement of $0.13 per share in our press release this morning. In addition, we continue to invest in our infrastructure and human capital to support our long-term growth strategies. As many of you know, our return on net asset standard is 20%, which means we focus on meeting or approaching that standard when making our investment decisions. The net assets we monitor include inventory, accounts receivable and fixed assets less accounts payable, tobacco taxes payable and accrued liabilities, all major components to our working capital management and monitored on a daily basis. For 2014, our RONA was just above 19% compared to 18% in 2013. Our capital allocation decisions support our core strategies and focus on ensuring we have sufficient capital to fund CapEx and related investments in our infrastructure, enable us to focus on acquisition and expansion activities, take advantage of opportunistic inventory buys and return value to you, our shareholders, through our dividend and share repurchase programs. To summarize, we had a good fourth third and a very good year in 2014, delivering record top line and EBITDA results. We’re very optimistic about 2015 in leveraging the foundation we are building for the future. And with that, I’d like to thank all of our employees, our vendors, our customers and you, our shareholders, for your continued support. Operator, you can now open the line for questions.